Pediatrix Medical Group, Inc. - Common Stock (MD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MD on NYSE
Shares outstanding
85,702,801
Price per share
$21.39
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
80,600,738
Total reported value
$1,349,887,440
% of total 13F portfolios
0%
Share change
-286,642
Value change
-$1,827,355
Number of holders
266
Price from insider filings
$21.39
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pediatrix Medical Group, Inc. - Common Stock (MD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $179,555,939 12,512,609 BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 3.7% $38,914,718 3,148,440 Rubric Capital Management LP 31 Dec 2024
ALLIANCEBERNSTEIN L.P. 2.2% -72% $27,805,682 -$71,010,122 1,928,272 -72% AllianceBernstein L.P. 31 May 2025

As of 30 Sep 2025, 266 institutional investors reported holding 80,600,738 shares of Pediatrix Medical Group, Inc. - Common Stock (MD). This represents 94% of the company’s total 85,702,801 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Pediatrix Medical Group, Inc. - Common Stock (MD) together control 71% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 13,849,278 -0.71% 0% $231,975,399
VANGUARD GROUP INC 13% 10,892,883 -0.84% 0% $182,455,791
VICTORY CAPITAL MANAGEMENT INC 4.8% 4,126,207 +31% 0.04% $69,113,968
STATE STREET CORP 4.1% 3,530,700 +1.2% 0% $59,139,225
DIMENSIONAL FUND ADVISORS LP 4% 3,399,778 +2.5% 0.01% $56,941,998
AMERICAN CENTURY COMPANIES INC 3.1% 2,682,976 +39% 0.02% $44,939,866
FMR LLC 2.6% 2,204,537 -8.7% 0% $36,925,990
GEODE CAPITAL MANAGEMENT, LLC 2.5% 2,167,291 +8.4% 0% $36,307,396
D. E. Shaw & Co., Inc. 2.4% 2,021,337 +28% 0.03% $33,857,395
Nuveen, LLC 1.8% 1,551,275 +85% 0.01% $25,983,857
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.7% 1,447,240 +14% 0% $24,241,270
Boston Partners 1.7% 1,427,953 +0.59% 0.02% $24,062,862
RENAISSANCE TECHNOLOGIES LLC 1.5% 1,306,000 +8.5% 0.03% $21,875,500
MORGAN STANLEY 1.5% 1,279,411 -2.8% 0% $21,430,146
Qube Research & Technologies Ltd 1.3% 1,143,306 +55% 0.03% $19,150,376
NORTHERN TRUST CORP 1.1% 932,680 +2.5% 0% $15,622,391
Invesco Ltd. 1% 877,019 +48% 0% $14,690,069
ALLIANCEBERNSTEIN L.P. 0.98% 839,886 -54% 0% $14,068,091
JPMORGAN CHASE & CO 0.97% 827,075 +20% 0% $13,853,506
Dana Investment Advisors, Inc. 0.94% 801,462 +5.6% 0.39% $13,424,489
GOLDMAN SACHS GROUP INC 0.89% 766,555 -3% 0% $12,839,789
CastleKnight Management LP 0.8% 682,000 -3.4% 0.61% $11,423,500
AMERIPRISE FINANCIAL INC 0.78% 671,749 -9.8% 0% $11,251,796
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.75% 646,792 +13% 0.23% $10,833,766
BRANDES INVESTMENT PARTNERS, LP 0.74% 630,711 +12% 0.08% $10,564,409

Institutional Holders of Pediatrix Medical Group, Inc. - Common Stock (MD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,659,747 $35,509,828 +$13,883,418 $21.39 27
2025 Q3 80,600,738 $1,349,887,440 -$1,827,355 $16.75 266
2025 Q2 80,728,834 $1,157,863,224 +$486,064 $14.35 264
2025 Q1 80,224,836 $1,161,325,326 -$29,361,456 $14.49 239
2024 Q4 82,290,662 $1,079,966,639 -$30,602,384 $13.12 227
2024 Q3 85,733,777 $993,673,643 -$12,231,978 $11.59 215
2024 Q2 87,369,732 $659,166,605 -$12,106,641 $7.55 223
2024 Q1 84,993,692 $852,207,915 +$34,610,446 $10.03 210
2023 Q4 82,188,568 $764,523,667 -$5,887,025 $9.30 221
2023 Q3 82,042,700 $1,042,835,627 -$2,900,348 $12.71 199
2023 Q2 81,528,991 $1,158,561,442 -$24,266,335 $14.21 209
2023 Q1 83,759,910 $1,248,743,727 -$7,502,166 $14.91 208
2022 Q4 84,388,114 $1,254,130,654 +$1,159,416 $14.86 202
2022 Q3 84,258,861 $1,391,433,449 -$43,448,133 $16.51 197
2022 Q2 86,490,179 $1,817,550,140 +$47,117,137 $21.01 187
2022 Q1 84,453,694 $1,983,111,191 +$15,656,033 $23.48 207
2021 Q4 83,789,475 $2,279,624,918 -$11,445,433 $27.21 196
2021 Q3 84,091,430 $2,390,560,820 -$125,656,043 $28.43 212
2021 Q2 88,508,524 $2,668,528,669 -$63,505,439 $30.15 212
2021 Q1 90,911,569 $2,315,371,131 -$23,389,852 $25.47 203
2020 Q4 92,058,476 $2,258,810,687 +$106,791,044 $24.54 192
2020 Q3 83,479,052 $1,358,832,149 -$39,891,998 $16.28 197
2020 Q2 85,777,576 $1,466,013,702 +$61,398,857 $17.10 201
2020 Q1 83,231,353 $968,853,295 -$26,947,411 $11.64 209
2019 Q4 78,540,960 $2,182,143,718 -$2,791,826 $27.79 251
2019 Q3 78,840,527 $1,782,780,485 -$6,934,386 $22.62 219
2019 Q2 79,054,519 $1,993,187,824 -$510,543 $25.23 238
2019 Q1 78,918,632 $2,144,069,706 -$118,881,793 $27.17 278
2018 Q4 82,328,556 $2,716,303,519 -$257,732,912 $33.00 293
2018 Q3 88,694,289 $4,137,248,940 -$32,221,833 $46.66 314
2018 Q2 90,230,985 $3,905,410,774 -$117,729,941 $43.28 316
2018 Q1 92,031,961 $5,118,722,535 -$86,567,667 $55.63 339
2017 Q4 93,596,765 $5,000,849,194 +$96,663,718 $53.44 323
2017 Q3 92,818,145 $4,002,496,859 -$196,613,862 $43.12 331
2017 Q2 94,859,395 $5,726,331,075 -$369,776,488 $60.37 327
2017 Q1 100,262,480 $6,954,874,567 +$634,431,911 $69.38 356
2016 Q4 98,751,503 $6,583,253,036 +$97,708,796 $66.66 381
2016 Q3 94,794,649 $6,277,453,187 +$163,638,549 $66.25 380
2016 Q2 92,327,762 $6,676,724,253 +$98,740,366 $72.43 387
2016 Q1 88,819,753 $5,744,317,903 -$31,317,321 $64.62 374
2015 Q4 95,530,464 $6,847,721,640 +$277,836,526 $71.66 396
2015 Q3 90,953,053 $6,985,029,453 -$724,797,608 $76.79 374
2015 Q2 97,202,644 $7,203,494,333 +$133,113,975 $74.11 356
2015 Q1 95,034,079 $6,887,622,948 -$164,723,218 $72.51 351
2014 Q4 97,461,526 $6,442,574,000 -$154,384,394 $66.11 332
2014 Q3 99,323,995 $5,445,164,402 +$36,506,691 $54.82 325
2014 Q2 98,740,602 $5,741,781,613 -$94,369,358 $58.15 331
2014 Q1 100,477,966 $6,226,479,350 -$136,235,726 $61.98 314